ClinicalTrials.gg
RecruitingNCT07060833Bubble CPAPUpdated Mar 30, 2026

Acoustics as a Metric of Airway Pressure in Premature Infants Using Bubble Continuous Positive Airway Pressure

An observational study in Preterm Infant, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Recruiting at 1 site in Canada. Open to participants aged 28 Weeks to 32 Weeks. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Observational

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
28 Weeks to 32 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 139 studies in Premature Birth with a site in Canada — 26 open to participants now, 34 under way, 2 of them phase 3. Premature Birth · Canada.

Planned enrollment
30th of 33
30 · median 144
Started
2025
with 6 others
Observational
33 of 139
9 open now
Primary completion
2026-09
later than 16 of 33 live
Registered
131st of 139
by date
Lead sponsor
7 of 139
McGill University Health Centre/Research Institute of the McGill University Health Centre

Among the 139 studies in Premature Birth with a site in Canada, this one is the 30th largest by planned enrollment of the 33 observational ones that give a count, is one of 7 that started in 2025, is one of 33 observational ones, reaches primary completion later than 16 of the 33 other live ones, and was the 131st registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

26 of the 139 studies in Premature Birth with a site in Canada are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 28 Weeks to 32 Weeks · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 139 studies in Premature Birth with a site in Canada, or all of them as a file.
02

Study summary

This is an observational, proof-of-concept, feasibility study where 30 preterm infants on bubble CPAP with gestational age \< 32+0 weeks will be recruited from the neonatal intensive care unit (NICU) at the Montreal Children's Hospital.

The study's main goals are:

  1. To determine the relationship between ambient bubbling sounds and delivered pressures in preterm infants on bCPAP.
  2. To determine the relationship between transmitted bubbling sounds and airway pressures transmitted to the lungs of preterm infants on bCPAP.
  3. To develop models to predict delivered and transmitted bCPAP pressures from the acoustic properties of bubbling sounds.
Read the detailed description

Continuous positive airway pressure (CPAP) is an essential, non-invasive therapy for treating various respiratory conditions in the Neonatal Intensive Care Units (NICU). CPAP is an effective treatment for respiratory distress syndrome, apneas, or after extubation, exerting its physiological benefits by maintaining upper airway patency and functional residual capacity. Bubble CPAP (bCPAP) is the most widely used CPAP due to its low cost and ease of use. It consists of an inspiratory tube carrying heated and humidified air, a nasal interface, and an expiratory tube immersed in a water chamber. The generation of bubbles in the water chamber by exhaled gas creates low amplitude and high-frequency pressure oscillations that are transmitted back to the chest. Successful CPAP requires constant transmission of the pressure via an unobstructed circuit. However, this is difficult to achieve in practice due to inadequate interface, leaks from an open mouth, and obstructed airway. As a result, bCPAP requires frequent manual checks by nurses and respiratory therapists to ensure that the circuit is secure and unobstructed.

As a proposed solution, bCPAP sounds heard in the patient room or upon auscultation are routinely used to assess the effectiveness of CPAP therapy. This sound can be heard both from the water tank creating the vibrations and during auscultation with a stethoscope, as the sound vibration is transmitted to the neonatal lungs. In the current era of digital technology, acoustic sounds can be converted to electronic signals for further processing and analysis.

We hypothesize that continuous recording and analysis of bCPAP sounds could be used as a proxy for real-time objective monitoring of the pressure transmitted to infants' lungs.

03

Conditions studied

  • Preterm Infant

Browse trials for

Keywords

  • Bubble CPAP
  • Airflow
  • Neonatal Intensive Care
  • Respiratory acoustics
  • Acoustic monitoring
  • Airway pressure monitoring
  • Bubbling sounds
04

Who can participate

Ages eligible
28 Weeks to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Preterm infants admitted to the neonatal intensive care unit at the Montreal Children's Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants on bCPAP with gestational age \< 32+0 weeks
  • Postmenstrual age between 28+0 and 36+6 weeks at the time of the study
  • Postnatal age greater than 168 hours (7 days) at the time of the study
  • On the bubble CPAP device with binasal prongs at the time of the study
  • Receiving bubble CPAP levels of 5 to 7 cm H2O with gas flows between 6L/min and 10L/min at the time of the study

Exclusion criteria

Exclusion Criteria:

  • Infants with known major congenital anomalies
  • Infants with known congenital heart disorders
  • Infants with known neuromuscular disease
  • Infants receiving ventilator-derived CPAP at the time of the study
  • Infants receiving CPAP via a nasal mask interface at the time of the study
  • Infants receiving inotropes, narcotics or sedative agents at the time of the study
  • Infants deemed clinically unstable for the study by the attending neonatologist
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Phase I: 15 preterm infants on Bubble Continuous Positive Airway Pressure (bCPAP)

    Group 1 will consist of 15 preterm infants on bCPAP in whom the external bubble CPAP sounds and the pressures from the CPAP system itself will be recorded for 3 hours. To do so, we will use a standard microphone placed on the water tank and an external pressure transducer inserted into the expiratory limb of the bubble CPAP circuit.

    Device: External pressure transducer · Device: Standard microphone

  • Phase II: 15 preterm infants on Bubble Continuous Positive Airway Pressure (bCPAP)

    Group 2 will consist of 15 preterm infants on bCPAP in whom the external bubble CPAP sounds and the pressures from the CPAP system itself will be recorded. To do so, we will use a standard microphone placed on the water tank and a pressure transducer inserted into the expiratory limb of the bubble CPAP circuit. In addition, the internal bubble CPAP sound and pressure transmitted to the infant's lungs will be measured. For these, a wireless acoustic sensor will be secured on the infant's suprasternal notch to capture transmitted CPAP sounds, and an internal pressure transducer will be inserted from the infant's mouth into the nasopharynx to record the pressure delivered in the airway. Data will be recorded for 3 hours.

    Device: External pressure transducer · Device: Standard microphone · Device: Wireless acoustic sensor · Device: Internal pressure transducer

Interventions

  • DeviceExternal pressure transducer

    The delivered CPAP pressure will be measured using an ultra-thin, multi-use catheter pressure transducer inserted into a port in the expiratory limb of the bubble CPAP circuit.

    Also known as: External catheter pressure transducer (Millar Mikro-tip ® SPR-524, 3.5F Single straight, Texas)

  • DeviceStandard microphone

    The bubble sound of the water tank will be collected with a standard condenser microphone directly affixed to the pole holding the water tank, with a secure clip.

    Also known as: Lavalier condenser microphone, Tosuny

  • DeviceWireless acoustic sensor

    The wireless acoustic sensor contains a dual microphone capable of capturing target sounds as well as ambient noise. The frequencies associated with ambient noise will be subtracted to maximize the signal-to-noise ratio of the bubble sound waveform. The wireless sensor will be placed on the suprasternal notch of the infant for monitoring the bubble sounds transmitted to the lungs and secured using a silicone-based tape approved for use in neonates. Data will be transmitted in real-time to a research-dedicated tablet using the Bluetooth Communication Controller and stored for future analysis.

  • DeviceInternal pressure transducer

    The transmitted CPAP pressure will be measured using an ultra-thin, single-use catheter pressure transducer inserted through the mouth to the level of the infant's nasopharynx. The data will be acquired with a sampling rate of 10kHz and stored for later analysis.

06

What researchers measure

Primary outcomes

  1. Pressure

    The mean pressure and the standard deviation of the pressure will be computed for each segment.

    Time frame: 3 hours

  2. External bubble CPAP sounds

    Two metrics will be computed: 1. The root mean square (RMS) 2. The power contained between a pre-determined range within each segment; We will determine the range that contains 80% of the signal power, in order to minimize other noises from bubble CPAP signal.

    Time frame: 3 hours

  3. Internal bubble CPAP sounds

    1. We will apply biomedical signal processing methods to separate the bubbling sounds from breathing sounds. Then, RMS and power will be computed. 2. We will use the Pearson correlation coefficient to compute the relationship between bubbling sound and pressure metrics. We will evaluate the linear regression models to identify the combination of sound metrics and covariates with the highest predictive accuracy.

    Time frame: 3 hours

07

Study locations

1 of 1 sites recruiting
  • McGill University Health Center
    Montreal, Quebec H4A 3J1, Canada
    Recruiting
    • Wissam Shalish, MD, PhD · Contactwissam.shalish@mcgill.ca · 514-412-4400
    • Wissam Shalish, MD PhD · Principal investigator
    • Guilherme Sant'Anna, MD PhD · Sub investigator
    • Robert Kearney, MD PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Sep 2026, 17 months after the start.

Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 17 months is below that.

Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2025
First posted
Jul 11, 2025
StartActual
Apr 3, 2025
Primary completionEst.
Sep 2026
CompletionEst.
Dec 2026
Last update
Mar 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07060833
Responsible party
Wissam Shalish (Assistant Professor, McGill University Health Centre/Research Institute of the McGill University Health Centre) — Principal investigator
First posted
Jul 11, 2025
Start date
Apr 3, 2025
Primary completion
Sep 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Mar 30, 2026

Study contacts

Wissam Shalish, MD, PhD
Contact
wissam.shalish@mcgill.ca
514-412-4400 ext. 22341
Wissam Shalish, MD PhD
principal investigator · McGill University Health Centre/Research Institute of the McGill University Health Centre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion